Gene Therapy
RCVD enhances myocardial plasmid expression
Published in Gene Therapy Weekly, September 29th, 2005
"Myocardial delivery of genes holds great promise for treating many heart diseases; however, the optimal delivery technique, which maximizes safety and efficacy, has not been established. Two delivery techniques were evaluated in swine; percutaneous retrograde coronary venous delivery (RCVD) and direct intramyocardial injection (IM). RCVD was performed in the anterior interventricular vein (AIV) with an end-hole occlusion balloon catheter," scientists in the United States report.
"The plasmid gWiz, encoding beta-galactosidase (10 ml; 1 mg/mL), was injected using either...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-09-29)
More Articles from Gene Therapy Weekly
- Breast Cancer
Bystander effect of INGN 241 increases cancer-killing activity in breast cancer - Gene Research
VEGF-A gene deletion disrupts thymus blood vessel architecture - Gene Therapy
ZAP-70 immunodeficiency corrected by intrathymic gene transfer - Vaccine Delivery
Degradable copolymers developed as novel gene carriers - Acute Myeloid Leukemia
Acute-leukemia sign may signal need for different therapy - Allergy & Immunology
Fas ligand from T cells may ignite hepatitis C-related liver inflammation - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
